Goals:

Determine responsiveness of SmO2 from CareGuide sensors across a physiological range

• To be included in FDA 510(k) submission
• Measure untrained subjects’ thighs, varying fat thickness
• Submaximal cycling test stepped in workloads until 80% max heart rate

Roles:

• Develop testing protocol and co-author IRB protocol
• Consent patients and guide them through data collection procedure
• Tech support of CareGuide systems during studies
• Data summary and analysis, author and graphic design of poster

Results:

Successful validation study and novel scientific findings

• Validated sensor on humans for original CareGuide FDA submission
• Found a difference between non dominant and dominant leg metabolism non-invasively
• Poster presented at 2012 American College of Sports Medicine meeting